SANGRIX INC. (BTOG) Form 6-K — Oct 23, 2026
Sangrix Inc. has called a shareholder meeting to approve a 1-for-10 reverse share consolidation of its Class A and Class B ordinary shares, effective November 13, 2026, reducing authorized shares from 200 billion to 20 billion. This is the company's third reverse split in under a year, following a 60-for-1 split in January 2026 and a 5-for-1 consolidation in August 2026 — moves driven by Nasdaq's $1.00 minimum bid price requirement. Because of those prior splits, Nasdaq rules leave the company ineligible for any compliance period: if the bid price fails for 30 consecutive trading days, the shares face immediate delisting.
Key figures
- Total Debt
- $8.44 million aggregate principal of outstanding secured convertible debentures
- Debt Amount
- 8440000
- Effective date
- 2026-11-13
- Reverse split ratio
- 1:10
- Prior reverse splits
- ["60:1 on 2026-01-20","5:1 on 2026-08-21"]
- Warrants outstanding
- 192154
- Warrant exercise price
- $1.63
- Authorized shares after
- 20,000,000,000
- Authorized shares before
- 200,000,000,000
- Prefunded warrant shares after
- 129158
- Prefunded warrant shares before
- 1291573
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.